These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8704277)

  • 1. Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.
    Archinal-Mattheis A; Rzepka RW; Watanabe T; Kokubu N; Itoh Y; Combates NJ; Bair KW; Cohen D
    Oncol Res; 1995; 7(12):603-10. PubMed ID: 8704277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Bollinger P; Loor F
    Cancer Res; 1991 Aug; 51(16):4226-33. PubMed ID: 1678313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats.
    Lemaire M; Bruelisauer A; Guntz P; Sato H
    Cancer Chemother Pharmacol; 1996; 38(5):481-6. PubMed ID: 8765444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SDZ PSC 833: a novel modulator of MDR].
    Covelli A
    Tumori; 1997; 83(5 Suppl):S21-4. PubMed ID: 9446255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833.
    Ehrlich PH; Moustafa ZA; Archinal-Mattheis AE; Newman MJ; Bair KW; Cohen D
    Anticancer Res; 1997; 17(1A):129-33. PubMed ID: 9066642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.
    Desrayaud S; De Lange EC; Lemaire M; Bruelisauer A; De Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1998 May; 285(2):438-43. PubMed ID: 9580581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SDZ PSC 833 ([3'-keto-Bmt1]-[Val2]-cyclosporin) on serum protein binding and distribution to blood cells of doxorubicin, vincristine and etoposide in vitro.
    Watanabe T; Iwasaki M; Todaka T; Morikawa H; Ohtawa M
    Anticancer Drugs; 1997 Apr; 8(4):400-4. PubMed ID: 9180396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.
    Watanabe T; Kokubu N; Charnick SB; Naito M; Tsuruo T; Cohen D
    Br J Pharmacol; 1997 Sep; 122(2):241-8. PubMed ID: 9313931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.
    Michieli M; Damiani D; Michelutti A; Melli C; Ermacora A; Geromin A; Fanin R; Russo D; Baccarani M
    Haematologica; 1996; 81(4):295-301. PubMed ID: 8870372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporine as drug resistance modifiers; mechanism and clinical investigation].
    Hama S; Kurisu K; Saijo N
    Nihon Rinsho; 1997 May; 55(5):1103-10. PubMed ID: 9155160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
    Jachez B; Nordmann R; Loor F
    J Natl Cancer Inst; 1993 Mar; 85(6):478-83. PubMed ID: 8095304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833.
    Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S20-4. PubMed ID: 9272129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
    Pétriz J; Sánchez J; Bertrán J; García-López J
    Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Watanabe T; Tsuge H; Koyama T; Oh-hara T; Tsuruo T
    Int J Cancer; 1996 Jul; 67(3):435-40. PubMed ID: 8707421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
    Friche E; Jensen PB; Nissen NI
    Cancer Chemother Pharmacol; 1992; 30(3):235-7. PubMed ID: 1628375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.
    Martinsson P; Nygren P; Fridborg H; Nilsson K; Kristensen J; Larsson R
    Eur J Clin Pharmacol; 1997; 52(3):199-203. PubMed ID: 9218926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.